Should You Buy Merck Stock After An Upbeat Q2?

Should You Buy Merck Stock After An Upbeat Q2?

Merck stock (NYSE: MRK) reported its Q2 results last week, with revenue and earnings comfortably above ours and the street estimates.

Generated by Feedzy